Menu Back to DIA-Global-Oncology-Development-2021

Overview

This event will be conducted online via Zoom.

Click Here to View the Program

We are offering a reduced participation fee for attendees from outside Japan. To claim this rate, please complete the registration form (see program link above) and email to DIA Japan at: japan@diaglobal.org 

Program Committee

  • Toshihiko  Doi, MD, PhD
    Toshihiko Doi, MD, PhD Deputy Director / Chief, Experimental Therapeutics
    National Cancer Center Hospital East, Japan
  • Noboru  Yamamoto, MD, PhD
    Noboru Yamamoto, MD, PhD Deputy Director, Department of Experimental Therapeutics
    National Cancer Center Hospital, Japan
  • Masakazu  Hirata, MD, PhD
    Masakazu Hirata, MD, PhD Review Director, Office of New Drug V
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Toshiko  Ishibashi, PhD, RN
    Toshiko Ishibashi, PhD, RN
    United States
  • Eri  Sekine
    Eri Sekine Region Head, Trial Monitoring, Japan Development, Global Development Ops.
    Novartis Pharma K.K., Japan
  • Takuya  Suzuki
    Takuya Suzuki Associate Director, Japan anad Asia Clinical Development Department
    Eisai Co., Ltd., Japan
  • Tomoko  Takami
    Tomoko Takami Director, Oncology Clinical Development, Oncology Science Unit
    MSD K.K., Japan
  • Atsushi  Tsukamoto, PhD, MSc
    Atsushi Tsukamoto, PhD, MSc
    United States
  • Hironobu  Saito, PhD
    Hironobu Saito, PhD Corporate Officer /Head of Medical Affairs Div.
    Daiichi Sankyo Co., Ltd., Japan
  • Junko  Sato, PhD
    Junko Sato, PhD Director, Office of International Programs
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Load More

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download